Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Ampio Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 26 | 29 | +3 |
| Shares | 2.35K | 47.6K | +45.3K (+1,928.6%) |
| Value | $8.44K | $96.8K | +$88.3K (+1,046.6%) |
New holders (5)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 19,580 | $40.1K | 0.00% |
| HRT Financial LP | 17,962 | $36.0K | 0.00% |
| CVA Family Office, LLC | 3,149 | $6.46K | 0.00% |
| Qube Research & Technologies Ltd | 1 | $2 | 0.00% |
| Royal Bank of Canada | 2 | $0 | 0.00% |
Sold out (2)
Institutions that held Ampio Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Stonebridge Capital Advisors LLC | 4 | $15 |
| FMR LLC | 2 | $7 |